CTKB Deferred Revenue

Cytek Biosciences Inc · Deferred Revenue

CTKB logo

CTKB Deferred Revenue

Latest reported$29.57M
CTKB FY Deferred Revenue ($3.47M → $29.57M)
High-resolution chart · PNG

CTKB deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytek Biosciences Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
29,572,000
26,610,000
24,133,000
14,541,000
8,099,000
4,289,000
3,471,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.